Even if specimens from humans with active NMO disease were available, it would likely be difficult to identify dead neurons because of their clearance, and the lack of a dead cell stain and defined AQP4-IgG exposure time as in the rat studies here. This evidence concerns the gene AQP4 and neuromyelitis optica.